Interventions for treating anxiety after stroke

Abstract

One study found that participants were less anxious three months after using a relaxation CD when compared with those who were given no therapy. One study reported that participants were less anxious when treated with an antidepressant medicine (paroxetine), or with paroxetine and psychotherapy, than with standard care. This study reported that half of the participants receiving paroxetine 2 Interventions for treating anxiety after stroke (Review)

Prevalence, Trajectory, and Factors Associated With Patient-Reported Nonmotor Outcomes After Stroke

“…We found that neuropsychiatric outcomes—such as anxiety, depression, fatigue, and sleep disturbance—were associated with 25.8% to 59.9% of individuals and persisted up to 10 years poststroke. Our pooled anxiety estimate of 26.9% aligns with previous studies but is a more precise estimate . One previous meta-analysis indicated a prevalence of 18.7% to 24.2% among 22 262 patients with stroke, while another with 44 studies (5760 patients) found an 18% to 25% prevalence.…”

“…Previous data on risk predictors of neuropsychiatric outcomes are conflicting; some studies suggest significant association with older age at stroke, others with young age at stroke for adverse prevalence risk . Similarly, gender associations vary, with some studies suggesting significant association between female sex with anxiety, depression, fatigue, and sleep disturbance, while others show male associations or none .…”

“…Initially, 817 studies met the inclusion criteria based on titles and abstracts. After further screening, 532 were excluded per criteria shown in eFigure 3 in in Supplement 1, leaving 279 studies for me...…”

“…Characteristics of the 279 included studies are shown in eTable 5 in Supplement 1. The total number of participants with stroke included in the meta-analysis was 117 440 (median [IQR] age, 65 [50-79] years; 209/279 studies…”

Prevalence, Trajectory, and Factors Associated With Patient-Reported Nonmotor Outcomes After Stroke

“…We found that neuropsychiatric outcomes—such as anxiety, depression, fatigue, and sleep disturbance—were associated with 25.8% to 59.9% of individuals and persisted up to 10 years poststroke. Our pooled anxiety estimate of 26.9% aligns with previous studies but is a more precise estimate . One previous meta-analysis indicated a prevalence of 18.7% to 24.2% among 22 262 patients with stroke, while another with 44 studies (5760 patients) found an 18% to 25% prevalence.…”

“…Previous data on risk predictors of neuropsychiatric outcomes are conflicting; some studies suggest significant association with older age at stroke, others with young age at stroke for adverse prevalence risk . Similarly, gender associations vary, with some studies suggesting significant association between female sex with anxiety, depression, fatigue, and sleep disturbance, while others show male associations or none .…”

“…Initially, 817 studies met the inclusion criteria based on titles and abstracts. After further screening, 532 were excluded per criteria shown in eFigure 3 in in Supplement 1, leaving 279 studies for me...…”

“…Characteristics of the 279 included studies are shown in eTable 5 in Supplement 1. The total number of participants with stroke included in the meta-analysis was 117 440 (median [IQR] age, 65 [50-79] years; 209/279 studies…”

Examination of Sleep Quality, Anxiety and Depression in Stroke Patients

“…GAD will make heavy demands on early and effective treatment (3). No information was available for stroke patients with anxiety only (19). We found that 33.3% of the patients had severe GAD.…”

Prevalence, Trajectory, and Factors Associated With Patient-Reported Nonmotor Outcomes After Stroke

“…We found that neuropsychiatric outcomes—such as anxiety, depression, fatigue, and sleep disturbance—were associated with 25.8% to 59.9% of individuals and persisted up to 10 years poststroke. Our pooled anxiety estimate of 26.9% aligns with previous studies but is a more precise estimate . One previous meta-analysis indicated a prevalence of 18.7% to 24.2% among 22 262 patients with stroke, while another with 44 studies (5760 patients) found an 18% to 25% prevalence.…”

“…Previous data on risk predictors of neuropsychiatric outcomes are conflicting; some studies suggest significant association with older age at stroke, others with young age at stroke for adverse prevalence risk . Similarly, gender associations vary, with some studies suggesting significant association between female sex with anxiety, depression, fatigue, and sleep disturbance, while others show male associations or none .…”

“…Initially, 817 studies met the inclusion criteria based on titles and abstracts. After further screening, 532 were excluded per criteria shown in eFigure 3 in in Supplement 1, leaving 279 studies for me...…”

“…Characteristics of the 279 included studies are shown in eTable 5 in Supplement 1. The total number of participants with stroke included in the meta-analysis was 117 440 (median [IQR] age, 65 [50-79] years; 209/279 studies…”

Examination of Sleep Quality, Anxiety and Depression in Stroke Patients

“…GAD will make heavy demands on early and effective treatment (3). No information was available for stroke patients with anxiety only (19). We found that 33.3% of the patients had severe GAD.…”

Prevalence, Trajectory, and Factors Associated With Patient-Reported Nonmotor Outcomes After Stroke

“…We found that neuropsychiatric outcomes—such as anxiety, depression, fatigue, and sleep disturbance—were associated with 25.8% to 59.9% of individuals and persisted up to 10 years poststroke. Our pooled anxiety estimate of 26.9% aligns with previous studies but is a more precise estimate . One previous meta-analysis indicated a prevalence of 18.7% to 24.2% among 22 262 patients with stroke, while another with 44 studies (5760 patients) found an 18% to 25% prevalence.…”

“…Previous data on risk predictors of neuropsychiatric outcomes are conflicting; some studies suggest significant association with older age at stroke, others with young age at stroke for adverse prevalence risk . Similarly, gender associations vary, with some studies suggesting significant association between female sex with anxiety, depression, fatigue, and sleep disturbance, while others show male associations or none .…”

“…Initially, 817 studies met the inclusion criteria based on titles and abstracts. After further screening, 532 were excluded per criteria shown in eFigure 3 in in Supplement 1, leaving 279 studies for me...…”

“…Characteristics of the 279 included studies are shown in eTable 5 in Supplement 1. The total number of participants with stroke included in the meta-analysis was 117 440 (median [IQR] age, 65 [50-79] years; 209/279 studies…”

Examination of Sleep Quality, Anxiety and Depression in Stroke Patients

“…GAD will make heavy demands on early and effective treatment (3). No information was available for stroke patients with anxiety only (19). We found that 33.3% of the patients had severe GAD.…”